Pharmacomicrobiomics in Psoriasis: Microbiome–Drug Interactions Across Systemic Treatments

Psoriasis is a chronic immune-mediated skin disease with highly variable responses to systemic therapies. Emerging evidence highlights the microbiome as a potential modulator of drug efficacy and toxicity. Gut bacteria can enzymatically metabolize drugs, such as methotrexate, altering bioavailabilit...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Umberto Santaniello, Luca Mastorino, Valentina Pala, Francois Rosset, Orsola Crespi, Pietro Quaglino, Simone Ribero
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-03-01
Cyfres:	Life
Pynciau:	psoriasis pharmacomicrobiomics microbiome gut microbiota skin microbiota drug metabolism
Mynediad Ar-lein:	https://www.mdpi.com/2075-1729/16/3/415
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!